In response to company growth and expansion of topical pharmaceutical product development services, Analytical Solutions of Research Triangle Park, N.C., has changed its name to Tergus Pharma, to better echo the company's new growth trajectory.

Tergus, Latin for "skin," is now providing dermatology drug development services from concept to commercialization.  With the acquisition of new equipment and strategic additions to the scientific team, Tergus Pharma now provides its clients with a broader range of topical drug development services, including product development strategy and design; target product profile development; formulation development; analytical method development and validation; preclinical and clinical supplies manufacturing; program management and logistics leadership; scale-up and technology transfer oversight; regulatory CMC consulting; disease model development; clinical development strategy; and development plan creation to ensure fastest path to in vivo or clinical proof of concept studies.

Tergus' core expertise will remain focused in topical dosage forms, including creams, ointments, lotions, liquids, suspensions, gels, hydrogels, pastes, pump sprays, topical aerosols, foams, microencapsulation, liposomes, suppositories and nail lacquers